Piracetam-induced neuroprotection in lipopolysaccharides-challenged EOC-20 cells and mouse brain via attenuating oxidative stress

Abstract Therapeutically, piracetam has been used for decades as a cognitive enhancer for memory- related neuronal disorders. The present study aimed to investigate the neuroprotective potential of piracetam on lipopolysaccharides (LPS)-induced neuronal deficit using both in-vitro and in-vivo experi...

Full description

Bibliographic Details
Published in:	Brazilian Journal of Pharmaceutical Sciences
Main Author:	Vasudevan Mani
Format:	Article
Language:	English
Published:	Universidade de São Paulo 2023-01-01
Subjects:	Neuroprotection Piracetam EOC-20 cells Neuroinflammation Antioxidant activity
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502022000100309&tlng=en

Similar Items

Piracetam as a Therapeutic Agent for Doxorubicin-Induced Cognitive Deficits by Enhancing Cholinergic Functions and Reducing Neuronal Inflammation, Apoptosis, and Oxidative Stress in Rats
by: Vasudevan Mani, et al.
Published: (2022-12-01)

Synergistic neurotrophic effects of piracetam and thiotriazoline
by: O. A. Gromova, et al.
Published: (2016-03-01)

Oral Piracetam in Patients with Chronic Vertigo
by: Özgür Akdoğan, et al.
Published: (2003-09-01)

Neuroprotective Effect of Piracetam against Cocaine-Induced Neuro Epigenetic Modification of DNA Methylation in Astrocytes
by: Kalaiselvi Sivalingam, et al.
Published: (2020-09-01)

A Comparative Study of the Prescription of Memantine and Piracetam in Poststroke Aphasia
by: Fariborz Khorvash, et al.
Published: (2015-12-01)

Synergy of piracetam and aminalon in the cerebroprotective effect of olatropyl.
by: V. I. Mamchur, et al.
Published: (2018-11-01)

Neurobehavioral Impacts of Xylazine and Piracetam Interaction on NADH Oxidase in the Rat Brain
by: Shaker M. Kermasha, et al.
Published: (2024-12-01)

Investigation of the Formation Process of Two Piracetam Cocrystals during Grinding
by: Keith Gordon, et al.
Published: (2011-10-01)

Elucidating the Three‐Dimensional Structure of Piracetam through Rotational Spectroscopy
by: S. Mato, et al.
Published: (2025-08-01)

„Cognitive Enhancement" or non-evidence-based nootropic abuse? – Use of Piracetam in Hungary
by: András Érszegi, et al.
Published: (2024-04-01)

The Effect of Piracetam against Acetyl Choline (Ach) In Behavioral Changes with Some Biochemical Parameters in Adult Mice
by: Bassam Al-Shimmary, et al.
Published: (2017-12-01)

Invasive epithelial ovarian carcinoma (EOC) at a young age: role of fertility-sparing
by: Puja Agung Antonius, et al.
Published: (2022-05-01)

The Effect of Piracetam Administration on Cerebral Palsy Prevention in Rat Fetuses Born To Pregnant Rats by Determining Bdnf Levels in Brain Tissue
by: Dudy Aldiansyah, et al.
Published: (2024-12-01)

Environmental sustainability profiles assessment of HPLC stability indicating method for quantitation of piracetam and vincamine in pharmaceutical medications
by: Samya Sh. Alenezi, et al.
Published: (2025-08-01)

Experimental substantiation of the expediency of the combined use of piracetam and metformin for pharmacological correction of cognitive disorders in conditions of prolonged hyperglycemia
by: А. E. Lievykh, et al.
Published: (2020-10-01)

Development and Preclinical Evaluation of Fixed-Dose Capsules Containing Nicergoline, Piracetam, and Hawthorn Extract for Sensorineural Hearing Loss
by: Lucia Maria Rus, et al.
Published: (2025-08-01)

Neuroprotection by Skimmianine in Lipopolysaccharide-Activated BV-2 Microglia
by: Folashade A. Ogunrinade, et al.
Published: (2023-01-01)

The Effect of Priacetam in Aphasia due to Acute Brain Ischemic Stroke: Clinical trial
by: A Hamzei-Moghaddam, et al.
Published: (2014-06-01)

The influence of Piracetam and Phenotropil on brain dopamine and serotonin metabolism in CD-1 mice sub-populations, diverging in attention sustainability
by: N. A. Sukhorukova, et al.
Published: (2022-02-01)

Exosomes released from M2 macrophages transfer miR‐221‐3p contributed to EOC progression through targeting CDKN1B
by: Xiaoduan Li, et al.
Published: (2020-08-01)

Neuroprotective Potential of Flavonoids in Brain Disorders
by: Syed Hasan, et al.
Published: (2023-08-01)

Dielectric Performance of Silica-Filled Nanocomposites Based on Miscible (PP/PP-HI) and Immiscible (PP/EOC) Polymer Blends
by: Xiaozhen He, et al.
Published: (2021-01-01)

Comparative pharmacokinetics and pharmacodinamics of noopept, its activity metabolite cycloprolylglycine and piracetam
by: Svetlana Boyko, et al.
Published: (2019-09-01)

Efficacy and safety of compound porcine cerebroside and ganglioside injection (CPCGI) versus piracetam on cognition and functional outcomes for adults with traumatic brain injury: A study protocol for randomized controlled trial
by: Tao Liu, et al.
Published: (2024-09-01)

Icariin attenuates neuroinflammation and exerts dopamine neuroprotection via an Nrf2-dependent manner
by: Bei Zhang, et al.
Published: (2019-04-01)

Betahistine’s Neuroprotective Actions against Lipopolysaccharide-Induced Neurotoxicity: Insights from Experimental and Computational Studies
by: Vasudevan Mani, et al.
Published: (2024-08-01)

Selective COX-2 Inhibitors as Neuroprotective Agents in Traumatic Brain Injury
by: Matthew I. Hiskens, et al.
Published: (2024-08-01)

Curcumin-Piperlongumine Hybrids with a Multitarget Profile Elicit Neuroprotection in In Vitro Models of Oxidative Stress and Hyperphosphorylation
by: Ángel Cores, et al.
Published: (2021-12-01)

Cannabidiol's neuroprotective properties and potential treatment of traumatic brain injuries
by: Mackenzie M. Aychman, et al.
Published: (2023-02-01)

Elucidating the pivotal molecular mechanisms, therapeutic and neuroprotective effects of lithium in traumatic brain injury
by: Seidu A. Richard
Published: (2024-06-01)

Development of quantitative structure activity relationships (QSARs) for predicting the aggregation of TiO2 nanoparticles under favorable conditions
by: Jaewoong Lee
Published: (2024-04-01)

Trehalose: Neuroprotective Effects and Mechanisms—An Updated Review
by: Borislav Sevriev, et al.
Published: (2024-10-01)

Hibiscetin attenuates oxidative, nitrative stress and neuroinflammation via suppression of TNF-α signaling in rotenone induced parkinsonism in rats
by: Sami I. Alzarea, et al.
Published: (2022-12-01)

Moss Extracts as Natural Neuroprotective Agents: Mitigating LPS-Induced Neuroinflammation and Microglial Activation
by: Tijana D. Stojanović, et al.
Published: (2025-05-01)

Isolation, Characterization and Neuroprotective Activity of Folecitin: An In Vivo Study
by: Umar Farooq, et al.
Published: (2021-08-01)

Vertigo in neurological practice (common problems of diagnosis and treatment)
by: Olga Vladimirovna Kosivtsova, et al.
Published: (2012-03-01)

Assessment of the prevalence of nootropic drugs by elderly patients in geriatric practice
by: Emilia Główczewska-Siedlecka, et al.
Published: (2017-08-01)

Current state of neuroprotective therapy using antibiotics in human traumatic brain injury and animal models
by: Katharina Ritter, et al.
Published: (2024-02-01)

Neuroprotective Effects of Berberine After Severe Traumatic Brain Injury in Male Rats: The Role of IL-1β and IL 10
by: Siavash Anbai, et al.
Published: (2022-01-01)

Probiotic treatment induces sex-dependent neuroprotection and gut microbiome shifts after traumatic brain injury
by: Morgan Holcomb, et al.
Published: (2025-04-01)